LEGISLATIVE SERVICES AGENCY
OFFICE OF FISCAL AND MANAGEMENT ANALYSIS
FISCAL IMPACT STATEMENT
LS 7594 NOTE PREPARED: Jan 10, 2025
BILL NUMBER: HB 1426 BILL AMENDED:
SUBJECT: Liability shield products.
FIRST AUTHOR: Rep. Borders BILL STATUS: As Introduced
FIRST SPONSOR:
FUNDS AFFECTED: GENERAL IMPACT: Pending
DEDICATED
FEDERAL
Summary of Legislation: Defines a "liability shield product" as a certain type of product that has been
designated as immune from liability under federal law. Requires a liability shield product to undergo a
placebo controlled study before it is distributed, manufactured, marketed, or administered. Requires: (1) the
Indiana department of health to monitor and publish certain information; and (2) certain entities to submit
documentation and compliance reports; concerning liability shield products. Allows the attorney general or
a private individual to bring an action if the requirements concerning liability shield products are not met.
Effective Date: Upon passage.
Explanation of State Expenditures: As of the above date, the fiscal analysis of this bill has not been
completed. Please contact the Office of Fiscal and Management Analysis for an update of this fiscal impact
statement.
Explanation of State Revenues:
Explanation of Local Expenditures:
Explanation of Local Revenues:
State Agencies Affected:
Local Agencies Affected:
Information Sources:
Fiscal Analyst: Allison Leeuw, 317-234-9465.
HB 1426 1